A 19,795-square-foot penthouse inside the Rivage Bal Harbour in Miami has hit the market at $75 million, marketed as the world's first "Human Optimization Residence." The listing, reported by Realtor.com, was conceived by Andrés Muñoz, founder of the luxury real estate firm MILLION, and his wife Madeleine Saade, who have spent two years working with ultra-high-net-worth clients in longevity research and have placed in the top 10 of the global Rejuvenation Olympics leaderboard. The three-level penthouse spans floors 23, 24, and 25 of a 25-storey, 56-residence tower designed by Skidmore, Owings & Merrill, and was developed by Related Group, Two Roads Development and Rockpoint.
The price is the punchline. The programming is the news.
The short version
- $75M asking for the final penthouse at Rivage Bal Harbour
- 19,795 sq ft across floors 23, 24 and 25
- Five bedrooms, six bathrooms, three powder rooms
- Conceived by MILLION's Andrés Muñoz and Madeleine Saade
- Developed with Related Group, Two Roads Development, Rockpoint
- Tower designed by Skidmore, Owings & Merrill
- Programming includes hyperbaric oxygen therapy, infrared and red light therapy, cold plunge, thermal recovery, circadian lighting, advanced air and water purification
- Sunset spa terrace with sauna, steam, hot tub, cold plunge
What this actually represents
The luxury residential pitch has long defaulted to the same trifecta: views, finishes, location. The Rivage penthouse — framed not as a trophy asset but as a residence designed to extend life — represents a category change. It pushes the amenity conversation past the gym and spa into measured biological performance.
The integration level matters more than the inventory list. A wellness room is an amenity. A home where circadian lighting, sleep-optimised bedroom design, air purification, water purification, and a recovery suite are wired into the architecture as the underlying brief — rather than added in a later renovation — is a different product. The implication is structural, not cosmetic.
This also reframes who buys at this level. The traditional trophy buyer purchased the view. The Human Optimization buyer is underwriting the building's effect on their own biomarkers over a multi-decade hold. That is a different underwriting problem and a different exit market.
Who should care
Developers, sponsors, and capital partners at the top of the market:
- The next tier of ultra-luxury product is being benchmarked on longevity programming, not surface finishes. Whoever defines that benchmark owns the comp set.
- The buyer pool for $50M-plus product is narrow and increasingly informed. Off-the-shelf wellness marketing reads as a miss.
- Related Group, Two Roads and Rockpoint have effectively set the floor for the next generation of branded-residence offerings. Expect other developers to licence the playbook rather than build it from scratch.
- Brokers, valuers, and analysts need to adjust comp frameworks. Two penthouses of similar size on the same barrier island can no longer be priced off view and finishes alone.
Everyone else:
Wellness design philosophies migrate downward, slowly. Circadian lighting and air purification are already filtering into mainline luxury and Class A multifamily. Watch the spread.
Underwriting checklist
When benchmarking branded-residence towers against the new comp set, add three items to your analysis:
- [ ] **Wellness programming depth**: Measured in dedicated square footage and architectural integration, not just amenity count.
- [ ] **Air and water purification**: Documented as a system, not a marketing line. Verify it appears in capex, not just the FF&E budget.
- [ ] **Sleep and circadian design**: Verifiable as a design choice, with documented cost in the construction stack.
Bottom line
The $75M number will move the conversation for a week. The integration of wellness into the architectural brief is the structural shift. Future top-end buyers underwrite health, not just square footage, and the comp set has just been redrawn. Watch whether any of the next three top-of-market launches quotes a human performance claim in their pitch deck. If they do, this is the new floor.
Key takeaways
- The $75M Rivage Bal Harbour penthouse is framed as the first "Human Optimization Residence," with longevity, recovery, and circadian systems built into the architecture rather than added later.
- Ultra-luxury product is being benchmarked on longevity programming depth, not surface finishes, reshaping comps for $50M-plus residences.
- Wellness design philosophies are filtering downward into mainline luxury and Class A multifamily over time.
Frequently asked questions
What is the "Human Optimization Residence" at Rivage Bal Harbour?
It is a $75M, 19,795-square-foot penthouse on floors 23–25 of the Rivage Bal Harbour tower, conceived by MILLION's Andrés Muñoz and Madeleine Saade and developed with Related Group, Two Roads Development, and Rockpoint, with programming centred on longevity, recovery, and circadian performance.
What wellness and longevity features are included?
The residence includes hyperbaric oxygen therapy, infrared and red light therapy, cold plunge, thermal recovery, circadian lighting, advanced air and water purification, and a sunset spa terrace with sauna, steam, hot tub, and cold plunge.
Why does this listing matter for the broader luxury market?
It shifts the luxury pitch from views and finishes to measured biological performance, redrawing the comp set at the top of the market and forcing developers, brokers, and valuers to price wellness integration into underwriting.
Who is the intended buyer for a residence like this?
Ultra-high-net-worth buyers underwriting the building's effect on their own biomarkers over a multi-decade hold, rather than trophy buyers optimising purely for view and finishes.
How might this trend spread to lower price tiers?
Circadian lighting, air purification, and sleep design are migrating downward from ultra-luxury into mainline luxury and amenity-rich Class A multifamily over time, with developers likely to licence the playbook rather than build it from scratch.